Orlistat in ObiNil is used to aid in weight loss, or to help reduce the risk of regaining weight already lost. This medicine must be used together with a reduced-calorie diet and increased physical activity. Orlistat is for use only in adults that are overweight or obese.
What is Orlistat in ObiNil for?
This medication is a lipase inhibitor, prescribed for obesity in adults. It works by blocking the digestion of fats from the diet. Orlistat stops about 30% of fat eaten from getting into the body
Common side effects of ObiNil:
Side effects are headache, back pain and belly pain.
What do I do if I miss a dose?
Skip the missed dose and go back to your normal time. Do not take 2 doses at the same time or extra doses.
What precautions should I take when taking ObiNil?
If you have an allergy to orlistat or any other part of this drug, tell your doctor if you are allergic to any drugs. Make sure to tell about the allergy and what signs you had. This includes telling about rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs. If you have any of these health problems: Gallbladder disease, malabsorption syndrome, or poor eating habits.
When do I need to seek medical help?
If you think there was an overdose, call your local poison control center or ER right away. Signs of a very bad reaction to the drug, these include wheezing; chest tightness; fever; itching; bad cough; blue or gray skin color; seizures; or swelling of face, lips, tongue, or throat. Very upset stomach or throwing up.
Can I take ObiNil with other medicines?
Sometimes drugs are not safe when you take them with certain other drugs and food. – Taking them together can cause bad side effects. – Be sure to talk to your doctor about all the drugs you take.
Are there any food restrictions
How do I store ObiNil?
Store in a cool, dry place away from the reach of children, medicines must not be used past the expiry date.
Category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.